ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
Dow Jones
38,675.68
1.18%
Brent Oil
82.765
0.00%
Bitcoin
63,081.69
0.31%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Maat Pharma SA (MAAT) Quote

Maat Pharma SA

Maat Pharma SA (MAAT)

Monash Absolute Active Trust
9.40
0.18
(1.95%)
Closed May 04 11:30AM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
9.40
Bid
9.32
Ask
9.40
Volume
336
9.24 Day's Range 9.40
4.50 52 Week Range 9.90
Market Cap
109.192M
Previous Close
9.22
Open
9.24
Last Trade
18
@
9.4
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
1,649
Shares Outstanding
11,616,199
Dividend Yield
-
PE Ratio
-5.54
Earnings Per Share (EPS)
-1.7
Revenue
2.23M
Net Profit
-19.72M

About Maat Pharma SA

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.maatpharma.com
Headquarters
Lyon, Rhone, Fra
Founded
1970
Maat Pharma SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker MAAT. The last closing price for Maat Pharma was 9.22 €. Over the last year, Maat Pharma shares have traded in a share price range of 4.50 € to 9.90 €.

Maat Pharma currently has 11,616,199 shares outstanding. The market capitalization of Maat Pharma is 109.19 € million. Maat Pharma has a price to earnings ratio (PE ratio) of -5.54.

MAAT Latest News

More News

MaaT Pharma to Hold Annual General Meeting on May 28, 2024

Regulatory News: MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to...

April 22 2024
Business Wire

MaaT Pharma présente lors de l'EBMT 2024 des données positives pour MaaT013 à 18 mois montrant un avantage net en termes de survie globale dans l'aGvH dans son programme d'accès compassionnel

Résultats positifs d'efficacité et de sécurité chez 140 patients traités avec le produit principal MaaT013 dans la maladie aiguë du greffon contre l'hôte dans le cadre du programme d'accès...

April 15 2024
Business Wire

MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital

Article 223-16 of the General Regulations of the Financial Markets Authority (AMF - Autorité des Marchés Financiers) Regulatory News: MaaT Pharma (EURONEXT: MAAT – the “Company”), a...

April 09 2024
Business Wire

MaaT Pharma présente des données précliniques prometteuses à l'AACR pour MaaT034 visant à améliorer les réponses des patients aux immunothérapies

Regulatory News: MaaT Pharma (EURONEXT : MAAT - la « Société »), société de biotechnologies en stade clinique avancé, leader dans le développement de Microbiome Ecosystem TherapiesTM (MET)1...

April 08 2024
Business Wire

MaaT Pharma annonce l’initiation de la couverture de son titre par Gilbert Dupont / Groupe Société Générale

Regulatory News: MaaT Pharma (EURONEXT : MAAT - la « Société »), société de biotechnologies en stade clinique avancé, leader dans le développement de Microbiome Ecosystem TherapiesTM (MET)1...

April 05 2024
Business Wire

MaaT Pharma publie ses résultats annuels pour l’année 2023 et fait un point sur ses activités

Le DSMB, sur la base des résultats préliminaires de l'essai de Phase 3 ARES, a conclu que MaaT013 a un rapport bénéfice/risque favorable avec "une efficacité élevée et une faible toxicité" dans...

March 28 2024
Business Wire

MaaT Pharma renforce son équipe de direction avec la nomination de Jonathan Chriqui au poste de Chief Business Officer

Regulatory News: MaaT Pharma (EURONEXT : MAAT - la « Société »), société de biotechnologies en stade clinique avancé, leader dans le développement de Microbiome Ecosystem TherapiesTM (MET)1...

March 21 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.343.75275938199.069.696889.29716673DE
40.262.844638949679.149.98.615539.20312621DE
122.1629.83425414367.249.96.8816498.7137942DE
261.722.07792207797.79.96.314817.88703976DE
520.323.524229074899.089.94.514467.19214265DE
156-4.1-30.370370370413.514.44.512719.75183089DE
260-4.1-30.370370370413.514.44.512719.75183089DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BENFBeneficient
$ 6.8001
(254.17%)
31.01M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M
SHOTWSafety Shot Inc
$ 0.45
(45.16%)
644
AIPArteris Inc
$ 8.185
(38.03%)
1.11M
RGFReal Good Food Company Inc
$ 0.85
(37.32%)
4.26M
MNDRMobile health Network Solutions
$ 3.33
(-84.91%)
18.76M
NUVOHoldco Nuvo Group DG Ltd
$ 2.00
(-57.54%)
1.04M
SPTSprout Social Inc
$ 28.82
(-40.15%)
13.47M
UNITUniti Group Inc
$ 4.441
(-26.35%)
21.07M
IPDNProfessional Diversity Network Inc
$ 1.29
(-24.12%)
662.59k
AAPLApple Inc
$ 183.38
(5.98%)
163.22M
SQQQProShares UltraPro Short QQQ
$ 11.08
(-5.94%)
154.59M
JAGXJaguar Health Inc
$ 0.3164
(7.91%)
142.47M
NKLANikola Corporation
$ 0.6526
(6.55%)
106.88M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M

Discussion

View Full Feed
ignatiusrielly35 ignatiusrielly35 17 minutes ago
You should have explained to them that if no law firm files to be lead counsel it indicates that nobody wants to go through the trouble of pursuing a very expensive frivolous case. Including the same ambulance chasing firm who started the whole thing, as they did last time, at the behest of the shor
AVXL
rikkie rikkie 19 minutes ago
I will save this message and respond to you shortly 🤔
LWLG
BigMoneyChalupa BigMoneyChalupa 22 minutes ago
You’re assuming the Supreme Court remands the case back to the district court for WNFT. I would strongly disagree that Calasses fraudulent actions from 2013 warrant any consideration from a legitimate court of appeals in the state of Nevada.

It is evident from the briefings and deali
WNFT
BirdsOfFire BirdsOfFire 22 minutes ago
Please have some patience. I believe they had to redesign the script on the cans as a result of my suggestion to the team developing the redesign of the can. Please be patient! As a former Technical Writer, I pointed out some errors in the development of the old cans. IMO
KGKG
Zorax Zorax 24 minutes ago
Obviously you've never discussed any of this with your wives or they would have killed you in your sleep.
I'm amazed you're alive today.
carlson carlson 28 minutes ago
BTC 63,153 USD was @ 56K USD just a short time ago!!!
CGAC
Zorax Zorax 28 minutes ago
mtg is living proof that sub humans can survive abortions.
ignatiusrielly35 ignatiusrielly35 29 minutes ago
Today (Friday) will establish another TZero. Then it may roll on from there.
GME
kennedytrading kennedytrading 31 minutes ago
The train is starting to move.
RDGL
BirdsOfFire BirdsOfFire 34 minutes ago
Please have some patience. I believe they had to redesign the script on the cans as a result of my suggestion to the team developing the redesign of the can. Please be patient! As a former Technical Writer, I pointed out some errors in the development of the old cans.
KGKG
Moonboy1 Moonboy1 37 minutes ago
Just a lower high is all we have so far. I'll take the pop for a flip but needs to get above 67,000 k for a sustained run. Maybe it will this time. Who knows anymore. One more bomb falls and its back down
BTCUSD
satter satter 39 minutes ago
Her testimony surely helps the prosecution in a big way. But she said a few things that could help the defense. It has been going mostly for prosecution but the defense has made some holes if I am being honest, the way I see it.

Can't lose sight that the defense only has to get one j
DJT
Zorax Zorax 39 minutes ago
You old coot or fake young coot. Now you're just trolling. Tights stretch.
Didn't you go around about this last summer?
chen1992 chen1992 42 minutes ago
What you are saying is let’s hope the DOE denies, allow it to go under .05, buy as many as possible, have trump win, and this skyrockets to the moon?! I’m all for it!!!!


It’s Trump’s election to lose. And this is coming from someone who voted for Obama and Biden
TGLO
in99flyers in99flyers 45 minutes ago
$16.52 closing price I believe is our highest closing price ever....I think we are just scratching the surface. $20 around the corner.
VTSI
Zorax Zorax 45 minutes ago
Putting a final guilty verdict in your own words does not make it not guilty.
You're showing more dementia problems than shittypants.
pdmihopefull pdmihopefull 53 minutes ago
To tjas part 2...if kgkg would of done half of the stuff they said they were going to do before the March Launch date...the kgkg stock would of had a chance to be trading at over a penny and who knows at what price it would be worth and trading at today... Duhhhh.......next week it might hit the tri
KGKG
RichieBoy RichieBoy 57 minutes ago
Guys I'm out as of a week ago.

My very first hesitation with SONX was extremely EARLY on. The realization the company was a FAMILY OFFICE run company. The whole concept felt a disturbing compromise for my interests which was volatility. Listen to your trader's gut carefully, it's ofte
SONX
DR_rugby DR_rugby 58 minutes ago
Well we still have

One more T

Thursday
Friday T1
Monday T2

Tuesday morning pre market will pin the tale on this show

It’s going to be good

Little more to go

But they are holding others bac
GME
cojoboy cojoboy 1 hour ago
Still waiting for ones DD..does that clown suit have starch in it..??😂😂😂😂
IGPK
Wise Man Wise Man 1 hour ago
The shareholders already filed a S.E.C. complaint in August 2020, denouncing the SPS LP and its offset with reduction of Retained Earnings account, absent from their balance sheets.
Posted at the end of https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174287126 this comment .
FNMA
sicofbs sicofbs 1 hour ago
Lol… as a source of potential fraud .. that’s what goes on here Everyday… we’ll ten said the hapless lawyer said … blah blah blah and on and on trying to trick people thinking shot like that is true … a paid penny pumper is now acceptable as dd 🤪 nothings happened since day one officially …
IGPK

Your Recent History

EU
MAAT
Maat Pharma
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved